HEADER TRANSFERASE 06-AUG-08 3E34 TITLE PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FPP AND ETHYLENEDIAMINE- TITLE 2 SCAFFOLD INHIBITOR 10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN FARNESYLTRANSFERASE/GERANYLGERANYLTRANSFERASE TYPE- COMPND 3 1 SUBUNIT ALPHA; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: CAAX FARNESYLTRANSFERASE SUBUNIT ALPHA, RAS PROTEINS COMPND 6 PRENYLTRANSFERASE ALPHA, FTASE-ALPHA, TYPE I PROTEIN GERANYL- COMPND 7 GERANYLTRANSFERASE SUBUNIT ALPHA, GGTASE-I-ALPHA; COMPND 8 EC: 2.5.1.58, 2.5.1.59; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: PROTEIN FARNESYLTRANSFERASE SUBUNIT BETA; COMPND 12 CHAIN: B; COMPND 13 SYNONYM: FTASE-BETA, CAAX FARNESYLTRANSFERASE SUBUNIT BETA, RAS COMPND 14 PROTEINS PRENYLTRANSFERASE BETA; COMPND 15 EC: 2.5.1.58; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: FNTA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 10 ORGANISM_COMMON: RAT; SOURCE 11 ORGANISM_TAXID: 10116; SOURCE 12 GENE: FNTB; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS FTASE, PROTEIN FARNESYLTRANSFERASE, FARNESYLTRANSFERASE, MALARIA, KEYWDS 2 PLASMODIUM, FALCIPARUM, ANTIMALARIAL, ETHYLENEDIAMINE, KEYWDS 3 PRENYLTRANSFERASE, TRANSFERASE, METAL-BINDING, PHOSPHOPROTEIN, ZINC EXPDTA X-RAY DIFFRACTION AUTHOR M.A.HAST,L.S.BEESE REVDAT 2 21-FEB-24 3E34 1 REMARK REVDAT 1 10-MAR-09 3E34 0 JRNL AUTH M.A.HAST,S.FLETCHER,C.G.CUMMINGS,E.E.PUSATERI, JRNL AUTH 2 M.A.BLASKOVICH,K.RIVAS,M.H.GELB,W.C.VAN VOORHIS,S.M.SEBTI, JRNL AUTH 3 A.D.HAMILTON,L.S.BEESE JRNL TITL STRUCTURAL BASIS FOR BINDING AND SELECTIVITY OF ANTIMALARIAL JRNL TITL 2 AND ANTICANCER ETHYLENEDIAMINE INHIBITORS TO PROTEIN JRNL TITL 3 FARNESYLTRANSFERASE. JRNL REF CHEM.BIOL. V. 16 181 2009 JRNL REFN ISSN 1074-5521 JRNL PMID 19246009 JRNL DOI 10.1016/J.CHEMBIOL.2009.01.014 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0077 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 68223 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3633 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.10 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4890 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.27 REMARK 3 BIN R VALUE (WORKING SET) : 0.2520 REMARK 3 BIN FREE R VALUE SET COUNT : 272 REMARK 3 BIN FREE R VALUE : 0.2950 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5948 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 374 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : 0.01000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.155 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.140 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.094 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.440 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6184 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8404 ; 1.256 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 728 ; 4.741 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 314 ;36.160 ;24.013 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1027 ;14.099 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 42 ;18.127 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 889 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4782 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3645 ; 0.627 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5885 ; 1.243 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2539 ; 1.988 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2519 ; 3.389 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3E34 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1000048814. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68223 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM ACETATE PH 5.7, 12% PEG8000, REMARK 280 DTT, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 23.15567 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 46.31133 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 34.73350 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 57.88917 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 11.57783 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 GLY A 6 REMARK 465 VAL A 7 REMARK 465 GLY A 8 REMARK 465 GLU A 9 REMARK 465 SER A 10 REMARK 465 ALA A 11 REMARK 465 PRO A 12 REMARK 465 GLY A 13 REMARK 465 GLY A 14 REMARK 465 GLU A 15 REMARK 465 PRO A 16 REMARK 465 GLY A 17 REMARK 465 GLN A 18 REMARK 465 PRO A 19 REMARK 465 GLU A 20 REMARK 465 GLN A 21 REMARK 465 PRO A 22 REMARK 465 PRO A 23 REMARK 465 PRO A 24 REMARK 465 PRO A 25 REMARK 465 PRO A 26 REMARK 465 PRO A 27 REMARK 465 PRO A 28 REMARK 465 PRO A 29 REMARK 465 PRO A 30 REMARK 465 ALA A 31 REMARK 465 GLN A 32 REMARK 465 GLN A 33 REMARK 465 PRO A 34 REMARK 465 GLN A 35 REMARK 465 GLU A 36 REMARK 465 GLU A 37 REMARK 465 GLU A 38 REMARK 465 MET A 39 REMARK 465 ALA A 40 REMARK 465 ALA A 41 REMARK 465 GLU A 42 REMARK 465 ALA A 43 REMARK 465 GLY A 44 REMARK 465 GLU A 45 REMARK 465 ALA A 46 REMARK 465 ALA A 47 REMARK 465 ALA A 48 REMARK 465 SER A 49 REMARK 465 PRO A 50 REMARK 465 MET A 51 REMARK 465 ASP A 52 REMARK 465 ASP A 53 REMARK 465 GLY A 54 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 SER B 5 REMARK 465 SER B 6 REMARK 465 PHE B 7 REMARK 465 THR B 8 REMARK 465 TYR B 9 REMARK 465 TYR B 10 REMARK 465 CYS B 11 REMARK 465 PRO B 12 REMARK 465 PRO B 13 REMARK 465 SER B 14 REMARK 465 SER B 15 REMARK 465 SER B 16 REMARK 465 GLU B 424 REMARK 465 GLU B 425 REMARK 465 CYS B 426 REMARK 465 GLU B 427 REMARK 465 ASP B 428 REMARK 465 ALA B 429 REMARK 465 VAL B 430 REMARK 465 THR B 431 REMARK 465 SER B 432 REMARK 465 ASP B 433 REMARK 465 PRO B 434 REMARK 465 ALA B 435 REMARK 465 THR B 436 REMARK 465 ASP B 437 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG B 291 O1A FPP B 1002 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 308 CA - CB - CG ANGL. DEV. = -17.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 88 47.15 35.94 REMARK 500 LEU A 215 56.49 -109.10 REMARK 500 THR A 247 -81.93 -114.43 REMARK 500 TYR A 292 78.11 -119.02 REMARK 500 PRO A 304 -70.83 -37.51 REMARK 500 HIS A 306 27.46 -142.71 REMARK 500 GLN A 326 77.00 34.48 REMARK 500 GLU A 347 -52.55 -134.08 REMARK 500 ASP A 349 52.71 -151.45 REMARK 500 SER B 39 17.72 58.02 REMARK 500 SER B 99 31.51 -140.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 297 OD2 REMARK 620 2 CYS B 299 SG 99.9 REMARK 620 3 HIS B 362 NE2 125.4 122.4 REMARK 620 4 ED1 B1003 NBJ 98.5 116.0 92.6 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FPP B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ED1 B 1003 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SA4 RELATED DB: PDB REMARK 900 RELATED ID: 1SA5 RELATED DB: PDB REMARK 900 RELATED ID: 2IEJ RELATED DB: PDB REMARK 900 RELATED ID: 1KZO RELATED DB: PDB REMARK 900 RELATED ID: 1KZP RELATED DB: PDB REMARK 900 RELATED ID: 1D8D RELATED DB: PDB REMARK 900 RELATED ID: 3E30 RELATED DB: PDB REMARK 900 FARNESYLTRANSFERASE COMPLEXED WITH FPP AND ETHYLENE DIAMINE REMARK 900 INHIBITOR 4 REMARK 900 RELATED ID: 3E32 RELATED DB: PDB REMARK 900 FARNESYLTRANSFERASE COMPLEXED WITH FPP AND ETHYLENEDIAMINE SCAFFOLD REMARK 900 INHIBITOR 2 REMARK 900 RELATED ID: 3E33 RELATED DB: PDB REMARK 900 FARNESYLTRANSFERASE COMPLEXED WITH FPP AND ETHYLENEDIAMINE SCAFFOLD REMARK 900 INHIBITOR 7 REMARK 900 RELATED ID: 3E37 RELATED DB: PDB REMARK 900 FARNESYLTRANSFERASE COMPLEXED WITH BISUBSTRATE ETHYLENEDIAMINE REMARK 900 SCAFFOLD INHIBITOR 5 DBREF 3E34 A 1 377 UNP Q04631 FNTA_RAT 1 377 DBREF 3E34 B 1 437 UNP Q02293 FNTB_RAT 1 437 SEQRES 1 A 377 MET ALA ALA THR GLU GLY VAL GLY GLU SER ALA PRO GLY SEQRES 2 A 377 GLY GLU PRO GLY GLN PRO GLU GLN PRO PRO PRO PRO PRO SEQRES 3 A 377 PRO PRO PRO PRO ALA GLN GLN PRO GLN GLU GLU GLU MET SEQRES 4 A 377 ALA ALA GLU ALA GLY GLU ALA ALA ALA SER PRO MET ASP SEQRES 5 A 377 ASP GLY PHE LEU SER LEU ASP SER PRO THR TYR VAL LEU SEQRES 6 A 377 TYR ARG ASP ARG ALA GLU TRP ALA ASP ILE ASP PRO VAL SEQRES 7 A 377 PRO GLN ASN ASP GLY PRO SER PRO VAL VAL GLN ILE ILE SEQRES 8 A 377 TYR SER GLU LYS PHE ARG ASP VAL TYR ASP TYR PHE ARG SEQRES 9 A 377 ALA VAL LEU GLN ARG ASP GLU ARG SER GLU ARG ALA PHE SEQRES 10 A 377 LYS LEU THR ARG ASP ALA ILE GLU LEU ASN ALA ALA ASN SEQRES 11 A 377 TYR THR VAL TRP HIS PHE ARG ARG VAL LEU LEU ARG SER SEQRES 12 A 377 LEU GLN LYS ASP LEU GLN GLU GLU MET ASN TYR ILE ILE SEQRES 13 A 377 ALA ILE ILE GLU GLU GLN PRO LYS ASN TYR GLN VAL TRP SEQRES 14 A 377 HIS HIS ARG ARG VAL LEU VAL GLU TRP LEU LYS ASP PRO SEQRES 15 A 377 SER GLN GLU LEU GLU PHE ILE ALA ASP ILE LEU ASN GLN SEQRES 16 A 377 ASP ALA LYS ASN TYR HIS ALA TRP GLN HIS ARG GLN TRP SEQRES 17 A 377 VAL ILE GLN GLU PHE ARG LEU TRP ASP ASN GLU LEU GLN SEQRES 18 A 377 TYR VAL ASP GLN LEU LEU LYS GLU ASP VAL ARG ASN ASN SEQRES 19 A 377 SER VAL TRP ASN GLN ARG HIS PHE VAL ILE SER ASN THR SEQRES 20 A 377 THR GLY TYR SER ASP ARG ALA VAL LEU GLU ARG GLU VAL SEQRES 21 A 377 GLN TYR THR LEU GLU MET ILE LYS LEU VAL PRO HIS ASN SEQRES 22 A 377 GLU SER ALA TRP ASN TYR LEU LYS GLY ILE LEU GLN ASP SEQRES 23 A 377 ARG GLY LEU SER ARG TYR PRO ASN LEU LEU ASN GLN LEU SEQRES 24 A 377 LEU ASP LEU GLN PRO SER HIS SER SER PRO TYR LEU ILE SEQRES 25 A 377 ALA PHE LEU VAL ASP ILE TYR GLU ASP MET LEU GLU ASN SEQRES 26 A 377 GLN CYS ASP ASN LYS GLU ASP ILE LEU ASN LYS ALA LEU SEQRES 27 A 377 GLU LEU CYS GLU ILE LEU ALA LYS GLU LYS ASP THR ILE SEQRES 28 A 377 ARG LYS GLU TYR TRP ARG TYR ILE GLY ARG SER LEU GLN SEQRES 29 A 377 SER LYS HIS SER ARG GLU SER ASP ILE PRO ALA SER VAL SEQRES 1 B 437 MET ALA SER SER SER SER PHE THR TYR TYR CYS PRO PRO SEQRES 2 B 437 SER SER SER PRO VAL TRP SER GLU PRO LEU TYR SER LEU SEQRES 3 B 437 ARG PRO GLU HIS ALA ARG GLU ARG LEU GLN ASP ASP SER SEQRES 4 B 437 VAL GLU THR VAL THR SER ILE GLU GLN ALA LYS VAL GLU SEQRES 5 B 437 GLU LYS ILE GLN GLU VAL PHE SER SER TYR LYS PHE ASN SEQRES 6 B 437 HIS LEU VAL PRO ARG LEU VAL LEU GLN ARG GLU LYS HIS SEQRES 7 B 437 PHE HIS TYR LEU LYS ARG GLY LEU ARG GLN LEU THR ASP SEQRES 8 B 437 ALA TYR GLU CYS LEU ASP ALA SER ARG PRO TRP LEU CYS SEQRES 9 B 437 TYR TRP ILE LEU HIS SER LEU GLU LEU LEU ASP GLU PRO SEQRES 10 B 437 ILE PRO GLN ILE VAL ALA THR ASP VAL CYS GLN PHE LEU SEQRES 11 B 437 GLU LEU CYS GLN SER PRO ASP GLY GLY PHE GLY GLY GLY SEQRES 12 B 437 PRO GLY GLN TYR PRO HIS LEU ALA PRO THR TYR ALA ALA SEQRES 13 B 437 VAL ASN ALA LEU CYS ILE ILE GLY THR GLU GLU ALA TYR SEQRES 14 B 437 ASN VAL ILE ASN ARG GLU LYS LEU LEU GLN TYR LEU TYR SEQRES 15 B 437 SER LEU LYS GLN PRO ASP GLY SER PHE LEU MET HIS VAL SEQRES 16 B 437 GLY GLY GLU VAL ASP VAL ARG SER ALA TYR CYS ALA ALA SEQRES 17 B 437 SER VAL ALA SER LEU THR ASN ILE ILE THR PRO ASP LEU SEQRES 18 B 437 PHE GLU GLY THR ALA GLU TRP ILE ALA ARG CYS GLN ASN SEQRES 19 B 437 TRP GLU GLY GLY ILE GLY GLY VAL PRO GLY MET GLU ALA SEQRES 20 B 437 HIS GLY GLY TYR THR PHE CYS GLY LEU ALA ALA LEU VAL SEQRES 21 B 437 ILE LEU LYS LYS GLU ARG SER LEU ASN LEU LYS SER LEU SEQRES 22 B 437 LEU GLN TRP VAL THR SER ARG GLN MET ARG PHE GLU GLY SEQRES 23 B 437 GLY PHE GLN GLY ARG CYS ASN LYS LEU VAL ASP GLY CYS SEQRES 24 B 437 TYR SER PHE TRP GLN ALA GLY LEU LEU PRO LEU LEU HIS SEQRES 25 B 437 ARG ALA LEU HIS ALA GLN GLY ASP PRO ALA LEU SER MET SEQRES 26 B 437 SER HIS TRP MET PHE HIS GLN GLN ALA LEU GLN GLU TYR SEQRES 27 B 437 ILE LEU MET CYS CYS GLN CYS PRO ALA GLY GLY LEU LEU SEQRES 28 B 437 ASP LYS PRO GLY LYS SER ARG ASP PHE TYR HIS THR CYS SEQRES 29 B 437 TYR CYS LEU SER GLY LEU SER ILE ALA GLN HIS PHE GLY SEQRES 30 B 437 SER GLY ALA MET LEU HIS ASP VAL VAL MET GLY VAL PRO SEQRES 31 B 437 GLU ASN VAL LEU GLN PRO THR HIS PRO VAL TYR ASN ILE SEQRES 32 B 437 GLY PRO ASP LYS VAL ILE GLN ALA THR THR HIS PHE LEU SEQRES 33 B 437 GLN LYS PRO VAL PRO GLY PHE GLU GLU CYS GLU ASP ALA SEQRES 34 B 437 VAL THR SER ASP PRO ALA THR ASP HET ZN B1001 1 HET FPP B1002 24 HET ED1 B1003 53 HETNAM ZN ZINC ION HETNAM FPP FARNESYL DIPHOSPHATE HETNAM ED1 3-{2'-[{[1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4- HETNAM 2 ED1 YL]METHYL}(2-{(4-CYANOPHENYL)[(1-METHYL-1H-IMIDAZOL-5- HETNAM 3 ED1 YL)METHYL]AMINO}ETHYL)SULFAMOYL]BIPHENYL-3- HETNAM 4 ED1 YL}PROPANOIC ACID FORMUL 3 ZN ZN 2+ FORMUL 4 FPP C15 H28 O7 P2 FORMUL 5 ED1 C40 H48 N6 O6 S FORMUL 6 HOH *374(H2 O) HELIX 1 1 LEU A 65 ALA A 73 5 9 HELIX 2 2 SER A 93 ASP A 110 1 18 HELIX 3 3 SER A 113 ASN A 127 1 15 HELIX 4 4 ASN A 130 LEU A 144 1 15 HELIX 5 5 ASP A 147 GLN A 162 1 16 HELIX 6 6 ASN A 165 LYS A 180 1 16 HELIX 7 7 GLN A 184 ASP A 196 1 13 HELIX 8 8 ASN A 199 ARG A 214 1 16 HELIX 9 9 ASN A 218 ASP A 230 1 13 HELIX 10 10 ASN A 233 THR A 247 1 15 HELIX 11 11 ASP A 252 VAL A 270 1 19 HELIX 12 12 ASN A 273 GLN A 285 1 13 HELIX 13 13 GLY A 288 ARG A 291 5 4 HELIX 14 14 TYR A 292 ASP A 301 1 10 HELIX 15 15 LEU A 302 SER A 307 1 6 HELIX 16 16 SER A 308 ASN A 325 1 18 HELIX 17 17 ASN A 329 GLU A 347 1 19 HELIX 18 18 ASP A 349 ILE A 351 5 3 HELIX 19 19 ARG A 352 SER A 368 1 17 HELIX 20 20 LEU B 23 ARG B 34 5 12 HELIX 21 21 THR B 42 ASN B 65 1 24 HELIX 22 22 GLN B 74 LEU B 86 1 13 HELIX 23 23 THR B 90 ASP B 97 5 8 HELIX 24 24 SER B 99 LEU B 114 1 16 HELIX 25 25 PRO B 119 GLN B 134 1 16 HELIX 26 26 HIS B 149 GLY B 164 1 16 HELIX 27 27 THR B 165 ILE B 172 1 8 HELIX 28 28 ASN B 173 LYS B 185 1 13 HELIX 29 29 ASP B 200 THR B 214 1 15 HELIX 30 30 GLY B 224 CYS B 232 1 9 HELIX 31 31 HIS B 248 LYS B 263 1 16 HELIX 32 32 LYS B 264 LEU B 268 5 5 HELIX 33 33 ASN B 269 SER B 279 1 11 HELIX 34 34 CYS B 299 GLN B 304 1 6 HELIX 35 35 GLY B 306 ALA B 317 1 12 HELIX 36 36 HIS B 331 CYS B 343 1 13 HELIX 37 37 ASP B 359 GLN B 374 1 16 HELIX 38 38 VAL B 389 VAL B 393 5 5 HELIX 39 39 GLY B 404 GLN B 417 1 14 SHEET 1 A 2 GLN A 89 ILE A 90 0 SHEET 2 A 2 GLN B 88 LEU B 89 1 O LEU B 89 N GLN A 89 SHEET 1 B 2 HIS B 375 SER B 378 0 SHEET 2 B 2 MET B 381 ASP B 384 -1 O HIS B 383 N PHE B 376 LINK OD2 ASP B 297 ZN ZN B1001 1555 1555 2.13 LINK SG CYS B 299 ZN ZN B1001 1555 1555 2.31 LINK NE2 HIS B 362 ZN ZN B1001 1555 1555 2.19 LINK ZN ZN B1001 NBJ ED1 B1003 1555 1555 2.19 SITE 1 AC1 3 ASP B 297 CYS B 299 HIS B 362 SITE 1 AC2 10 LYS A 164 TYR A 166 HIS B 248 GLY B 250 SITE 2 AC2 10 CYS B 254 ARG B 291 LYS B 294 TYR B 300 SITE 3 AC2 10 HOH B2641 HOH B2679 SITE 1 AC3 17 LYS A 164 TYR A 166 GLN A 167 HOH A2724 SITE 2 AC3 17 HOH A2801 TYR B 93 LEU B 96 TRP B 102 SITE 3 AC3 17 ALA B 151 ARG B 202 ASP B 297 TRP B 303 SITE 4 AC3 17 ASP B 359 PHE B 360 TYR B 361 HIS B 362 SITE 5 AC3 17 HOH B1550 CRYST1 170.169 170.169 69.467 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005877 0.003393 0.000000 0.00000 SCALE2 0.000000 0.006786 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014395 0.00000